In addition to breast cancer, the potential of Capivasertib in the treatment of other types of cancer (such as prostate cancer, lung cancer and renal cell cancer) is also gradually emerging.
With the development of precision medicine, Capivasertib may be combined with genetic testing technology to achieve more personalized cancer treatment.